Mucormycosis is a relatively rare but extremely aggressive fungal infection that commonly
affects patients who are compromised hosts. These infections typically come in various
patterns: pulmonary, sinus, rhinocerebral, cerebral, cutaneous, or disseminated forms.
Treatment usually consists of a combination of antifungal agents and surgical debridement,
although morbidity and mortality are high. In this case report, we describe the course
of a patient with a disseminated Mucor infection, primarily involving the upper extremities, who was successfully treated
with topical and systemic antifungal agents without the need for surgical intervention.
Key words
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Hand SurgeryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Mucormycoses.Mycoses. 2001; 44: 253-260
- Epidemiology and outcome of zygomycosis: a review of 929 reported cases.Clin Infect Dis. 2005; 41: 634-653
- Why is mucormycosis more difficult to cure than more common mycoses?.Clin Microbiol Infect. 2014; 20: 74-81
- Upper-extremity mucormycosis infections in immunocompetent patients.J Hand Surg Am. 2006; 31: 1201-1205
- Cutaneous mucormycosis of the upper extremity in an immunocompetent host: case report.J Hand Surg Am. 2012; 37: 787-791
- ESCMID and ECMM Joint Clinical Guidelines for the Diagnosis and Management of Mucormycosis 2013.Clin Microbiol Infect. 2014; 20: 5-26
- Diagnosis and treatment of upper extremity mucormycosis infections.J Hand Surg Am. 2015; 40: 1032-1034
- The contemporary management and clinical outcomes of mucormycosis: a systematic review and meta-analysis of case reports.Int J Antimicrob Agents. 2019; 53: 589-597
- Successful management of cutaneous mucormycosis by delaying debridement.Ann Plast Surg. 2012; 69: 301-306
- Myocutaneous mucormycosis in a diabetic burnt patient led to upper extremity amputation: a case report.Bull Emerg Trauma. 2017; 5: 58-62
- Successful treatment of invasive mucormycosis in a liver transplant patient by arm amputation.Transplant Proc. 2010; 42: 2794-2796
- Surgical wound mucormycosis necessitating hand amputation: a case report.J Orthop Surg (Hong Kong). 2008; 16: 267-269
- Mucormycosis osteomyelitis of the hand.J Hand Surg Am. 2019; 44: 424.e1-424.e4
- Mucormycosis of the upper extremity in a patient with alcoholic encephalopathy.J Hand Surg Am. 2007; 32: 384-388
- Topical amphotericin B in combination with standard therapy for severe necrotizing skin and soft-tissue mucormycosis in an infant with bilineal leukemia: case report and review.J Pediatr Hematol Oncol. 2014; 36: e468-e470
- Efficacious topical treatment for murine cutaneous leishmaniasis with ethanolic formulations of amphotericin B.Antimicrob Agents Chemother. 1998; 42: 3092-3096
Article info
Publication history
Published online: March 23, 2020
Accepted:
January 31,
2020
Received:
May 15,
2019
Footnotes
No benefits in any form have been received or will be received related directly or indirectly to the subject of this article.
Identification
Copyright
© 2020 by the American Society for Surgery of the Hand. All rights reserved.
